SAN FRANCISCO, May 9 OxyBand Technologies, Inc. todayannounced that it has signed a contract with the United States Army toevaluate the company's patented cutting edge wound healing technology forbattlefield and other military wounds. OxyBand Technologies has developed aproprietary wound dressing that delivers pure oxygen gas into wounds forfaster healing. The OxyBand dressing has been shown in clinical trials toaccelerate healing and, in laboratory testing, to reduce bacteria forinfection. The OxyBand Wound Dressing has received FDA 510(k) clearance forboth prescription (Rx) and over the counter (OTC) marketing.
"This initial contract with the Army establishes a great position forOxyBand to further demonstrate the OxyBand wound healing prowess and moves uscloser to our goal of providing a real benefit to the men and women defendingour country," said Dr. Amie Franklin, CEO of OxyBand Technologies.
OxyBand Technologies has developed a proprietary technology for packagingpure oxygen into a discrete wound dressing using directionally permeable gas-emitting reservoirs. The resulting dressing has been shown in randomized,controlled double-blind trials to significantly accelerate wound healing,reduce inflammation, redness and pain through the direct and sustainedapplication of pure oxygen over several days.
Funding under this new Army contract is for an evaluation of OxyBanddressings for accelerated healing of battlefield and other wounds, which is ofconcern to the U.S. military. OxyBand anticipates beginning work under thecontract with the United States Army Medical Research and Material Command(USAMRMC) immediately. The clinical study evaluating OxyBand Dressings will beconducted at the United States Army Institute for Surgical Research, (USAISR)which is a part of the USAMRMC and is co-located with Brooke Army MedicalCenter.
"As part of our overall program to improve the care given to woundedmilitary service members, we are looking forward to continuing to work withOxyBand in order to determine the effect of their innovative dressing on woundhealing in burn patients. We see great potential in this approach fordelivering oxygen directly to wounds and are hopeful that it will have broadapplicability in acute wound care," said Dr David Baer, the Director for theOffice of Research for the US Army Institute of Surgical Research, ProgramArea Manager for Bone and Soft Tissue Trauma Research, DTO Manager for DefenseTechnology Objective MD.30 (Battlefield Treatment of Fractures and Soft TissueTrauma Care), STO Manager for Science and Technology for both Objective S andF (Soft Tissue Trauma Care) and Battlefield Treatment of Fractures), anaffiliate member of the McGowan Institute for Regenerative Medicine inPittsburgh, PA.
The USAISR mission is to provide requirements-driven combat casualty caremedical solutions and products for injured soldiers, from self-aid throughdefinitive care across the full spectrum of military operations; providestate-of-the-art trauma, burn, and critical care to Department of Defenseeficiaries around the world and civilians; and provide Burn Special MedicalAugmentation Response Teams.
"We are proud to be working with the USAMRMC and the USAISR," added Dr.Franklin. "We are confident OxyBand Dressings can provide a needed solutionfor accelerating healing of battlefield and other wounds and we look forwardto helping the men and women serving in the military."
For more information please contact OxyBand Technologies Inc. firstname.lastname@example.org or at 415 283 3356.
SOURCE OxyBand Technologies, Inc.